Clinical trial
Multicenter Prospective Registry of PCI With a New Generation Everolimus- Eluting Stent for Unprotected Left Main Coronary Artery Disease
NCT01256723 is registered in ClinicalTrials.gov with Associations for Establishment of Evidence in Interventions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Prospective Registry of PCI With a New Generation Everolimus- Eluting Stent for Unprotected Left Main Coronary Artery Disease
- Lead sponsor
- Associations for Establishment of Evidence in Interventions
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2010
- Completion date
- May 31, 2018
- Enrollment
- 441 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.